IBDEI2N1 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44272,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,44273,0)
 ;;=N20.1^^200^2224^9
 ;;^UTILITY(U,$J,358.3,44273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44273,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,44273,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,44273,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,44274,0)
 ;;=N18.9^^200^2224^18
 ;;^UTILITY(U,$J,358.3,44274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44274,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,44274,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,44274,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,44275,0)
 ;;=N18.6^^200^2224^28
 ;;^UTILITY(U,$J,358.3,44275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44275,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,44275,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,44275,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,44276,0)
 ;;=N52.9^^200^2224^44
 ;;^UTILITY(U,$J,358.3,44276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44276,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,44276,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,44276,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,44277,0)
 ;;=N32.81^^200^2224^75
 ;;^UTILITY(U,$J,358.3,44277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44277,1,3,0)
 ;;=3^Overactive Bladder
 ;;^UTILITY(U,$J,358.3,44277,1,4,0)
 ;;=4^N32.81
 ;;^UTILITY(U,$J,358.3,44277,2)
 ;;=^5015652
 ;;^UTILITY(U,$J,358.3,44278,0)
 ;;=Q61.2^^200^2224^79
 ;;^UTILITY(U,$J,358.3,44278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44278,1,3,0)
 ;;=3^Polycystic Kidney,Adult Type
 ;;^UTILITY(U,$J,358.3,44278,1,4,0)
 ;;=4^Q61.2
 ;;^UTILITY(U,$J,358.3,44278,2)
 ;;=^5018796
 ;;^UTILITY(U,$J,358.3,44279,0)
 ;;=N41.1^^200^2224^83
 ;;^UTILITY(U,$J,358.3,44279,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44279,1,3,0)
 ;;=3^Prostatitis,Chronic
 ;;^UTILITY(U,$J,358.3,44279,1,4,0)
 ;;=4^N41.1
 ;;^UTILITY(U,$J,358.3,44279,2)
 ;;=^186931
 ;;^UTILITY(U,$J,358.3,44280,0)
 ;;=N11.9^^200^2224^91
 ;;^UTILITY(U,$J,358.3,44280,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44280,1,3,0)
 ;;=3^Pyelonephritis,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,44280,1,4,0)
 ;;=4^N11.9
 ;;^UTILITY(U,$J,358.3,44280,2)
 ;;=^5015574
 ;;^UTILITY(U,$J,358.3,44281,0)
 ;;=N20.9^^200^2224^102
 ;;^UTILITY(U,$J,358.3,44281,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44281,1,3,0)
 ;;=3^Urinary Calculus,Unspec
 ;;^UTILITY(U,$J,358.3,44281,1,4,0)
 ;;=4^N20.9
 ;;^UTILITY(U,$J,358.3,44281,2)
 ;;=^5015610
 ;;^UTILITY(U,$J,358.3,44282,0)
 ;;=R51.^^200^2225^2
 ;;^UTILITY(U,$J,358.3,44282,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44282,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,44282,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,44282,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,44283,0)
 ;;=G44.1^^200^2225^9
 ;;^UTILITY(U,$J,358.3,44283,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44283,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,44283,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,44283,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,44284,0)
 ;;=G43.909^^200^2225^5
 ;;^UTILITY(U,$J,358.3,44284,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44284,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,44284,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,44284,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,44285,0)
 ;;=G44.009^^200^2225^1
 ;;^UTILITY(U,$J,358.3,44285,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44285,1,3,0)
 ;;=3^Cluster Headache,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,44285,1,4,0)
 ;;=4^G44.009
 ;;^UTILITY(U,$J,358.3,44285,2)
 ;;=^5003921
 ;;^UTILITY(U,$J,358.3,44286,0)
 ;;=G44.40^^200^2225^4
